H.R. 124 · 119th Congress

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

Stage
In committee
Sponsor
Al Green
Introduced
2025-01-03
Latest action
2025-01-03 · Introduced in House

Summary

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 [sic]

This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)